IRVINE, CALIF., December 2 – BioDuro, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the appointment of Alan Findlater as Chief Commercial Officer.
With over 25 years of senior commercial leadership experience in the life sciences and pharmaceutical services industry, Findlater brings a proven track record of leading high-performing teams of up to 150 professionals, managing complex product and service portfolios, building high-value partnerships with industry leaders including Amgen, Pfizer and Roche, and executing successful strategic growth initiatives on a global scale.
Findlater holds a bachelor's in chemistry from the University of Strathclyde and an MBA from Warwick Business School, both in the UK.
“We are thrilled to welcome Alan Findlater to the BioDuro executive team,” said Dr. Armin Spura, CEO of BioDuro. “Alan's vast experience and successful track record in the life sciences industry will be invaluable as we continue to enhance our commercial strategy, drive commercial success, and deliver innovative client-centric solutions that strengthen our market leadership.”
About BioDuro
BioDuro, an Advent International portfolio company, is a CRDMO with a 28-year proven track record. Headquartered in Irvine, California, USA, our global presence spans 7 sites across the United States and China, with over 2,000 employees. Specializing in both small and large molecule discovery, development, scale-up, and manufacturing, we offer fully integrated services from early drug discovery to commercial manufacturing across chemistry, biology, DMPK, drug substance, and drug product.
Home